Upload your Marketing & Sales content on your company Virtual Booth, click HERE.
Details:
Rotigotine is non-ergoline dopamine agonist approved for treatment of Parkinson’s disease and restless legs syndrome.Active pharmaceutical ingredient is not well absorbed via oral delivery and is formulated as a once-daily TDS patch to increase bioavailability.
Lead Product(s): Rotigotine
Therapeutic Area: Neurology Product Name: ROV045
Highest Development Status: IND EnablingProduct Type: Small molecule
Partner/Sponsor/Collaborator: Not Applicable
Deal Size: Not Applicable Upfront Cash: Not Applicable
Deal Type: Not Applicable October 18, 2022
Details:
The company will use net proceeds of the financing to fund its research, development and commercialization activities for its lead Rotigotine and other pipeline candidates and for general working capital.
Lead Product(s): Rotigotine
Therapeutic Area: Neurology Product Name: Undisclosed
Highest Development Status: Phase I/ Phase IIProduct Type: Small molecule
Partner/Sponsor/Collaborator: Undisclosed
Deal Size: $3.6 million Upfront Cash: Undisclosed
Deal Type: Financing September 02, 2022
Details:
The Company will use net proceeds of the placement to fund its research, development and commercialization activities especially for it's lead rotigotine and for general working capital.
Lead Product(s): Rotigotine
Therapeutic Area: Neurology Product Name: ROV045
Highest Development Status: IND EnablingProduct Type: Small molecule
Partner/Sponsor/Collaborator: Undisclosed
Deal Size: $1.8 million Upfront Cash: Undisclosed
Deal Type: Private Placement August 31, 2022
Details:
The programs include in-vitro study of thin film delivery of cannabigerol and quercetin for potential anti-bacterial and anti-viral treatments as well as development of point-of-care sensor-film.
Lead Product(s): Cannabigerol
Therapeutic Area: Infections and Infectious Diseases Product Name: Undisclosed
Highest Development Status: IND EnablingProduct Type: Small molecule
Partner/Sponsor/Collaborator: Not Applicable
Deal Size: Not Applicable Upfront Cash: Not Applicable
Deal Type: Not Applicable March 03, 2020